Claudia Maggi

1.8k total citations · 1 hit paper
36 papers, 1.3k citations indexed

About

Claudia Maggi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Claudia Maggi has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Claudia Maggi's work include Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Treatment and Pharmacology (6 papers). Claudia Maggi is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Treatment and Pharmacology (6 papers). Claudia Maggi collaborates with scholars based in Italy, China and Spain. Claudia Maggi's co-authors include Filippo de Braud, Filippo Pietrantonio, Maria Di Bartolomeo, Roberto Iacovelli, Ilaria Bossi, Fausto Petrelli, Sandro Barni, Andrea Coinu, Mary Cabiddu and Karen Borgonovo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Claudia Maggi

36 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis

2015 350 citations Filippo Pietrantonio, Fausto Petrelli et al. profile →

Peers

Countries citing papers authored by Claudia Maggi

Since Specialization

Citations

This map shows the geographic impact of Claudia Maggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Maggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Maggi more than expected).

Fields of papers citing papers by Claudia Maggi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Maggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Maggi. The network helps show where Claudia Maggi may publish in the future.

Co-authorship network of co-authors of Claudia Maggi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Maggi. A scholar is included among the top collaborators of Claudia Maggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Maggi. Claudia Maggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 ·Critical Reviews in Oncology/Hematology ·Claudio Vernieri, Monica Milano, Marta Brambilla, Alessia Mennitto, Claudia Maggi, Maria Silvia Cona, Michele Prisciandaro, Chiara Fabbroni, Luigi Celio, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	158
2	The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer 2018 ·Scientific Reports ·Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, Veronica Huber, Monica Milano, L. Rinaldi, Maria Silvia Cona, Claudia Maggi, (unknown), Siranoush Manoukian, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Licia Rivoltini, Filippo de Braud	45
3	Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles 2018 ·Clinical Breast Cancer ·Claudio Vernieri, Michele Prisciandaro, Monica Milano, Maria Silvia Cona, Claudia Maggi, Marta Brambilla, Alessia Mennitto, Chiara Fabbroni, Elena Farè, Sara Cresta, Luigi Celio, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	11
4	Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study 2017 ·Breast Cancer Research and Treatment ·Claudio Vernieri, Monica Milano, Alessia Mennitto, Claudia Maggi, (unknown), L. Rinaldi, (unknown), (unknown), (unknown), Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	9
5	Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy 2016 ·The Breast ·Maria Carmen De Santis, (unknown), F. Di Salvo, (unknown), (unknown), F. Soncini, Paolo Baili, Milena Sant, Giulia Bianchi, Claudia Maggi, Serena Di Cosimo, Roberto Agresti, E. Pignoli, R. Valdagni, Laura Lozza	34
6	GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study 2016 ·Journal of Translational Medicine ·Filippo Pietrantonio, Rosa Berenato, Claudia Maggi, Marta Caporale, Massimo Milione, Federica Perrone, Elena Tamborini, Dario Baratti, Shigeki Kusamura, Luigi Mariani, Monica Niger, Alessia Mennitto, Annunziata Gloghini, Ilaria Bossi, (unknown), Adele Busico, (unknown), Maria Di Bartolomeo, Marcello Deraco, Filippo de Braud	37
7	Ramucirumab: an update 2015 ·Maria Di Bartolomeo, Rosa Berenato, Claudia Maggi, Filippo Pietrantonio	1
8	Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 2015 ·Medical Oncology ·Filippo Pietrantonio, Vincenzo Mazzaferro, Rosalba Miceli, Christian Cotsoglou, (unknown), Giuseppe Fanetti, Federica Perrone, Pamela Biondani, (unknown), Maria Di Bartolomeo, Jorgelina Coppa, Claudia Maggi, Massimo Milione, Elena Tamborini, Filippo de Braud	22
9	First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis 2015 ·Critical Reviews in Oncology/Hematology ·Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, Maria Di Bartolomeo, Fotios Loupakis, Claudia Maggi, Carlotta Antoniotti, Filippo de Braud, Alfredo Falcone, Roberto Iacovelli	60
10	Treatment of elderly patients with metastatic renal cell carcinoma 2015 ·Expert Review of Anticancer Therapy ·Elisa Zanardi, Paolo Grassi, Alessia Cavo, Elena Verzoni, Claudia Maggi, Filippo de Braud, Francesco Boccardo, Giuseppe Procopio	7
11	Bevacizumab treatment in the elderly patient with metastatic colorectal cancer 2015 ·Clinical Interventions in Aging ·Maria Di Bartolomeo, Claudia Maggi, (unknown), Filippo Pietrantonio, Roberto Iacovelli, Filippo de Braud, Alessandro Inno	5
12	<b><i>TP53</i></b> Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon 2014 ·Oncology ·Filippo Pietrantonio, Pamela Biondani, Federica Perrone, Maria Di Bartolomeo, Monica Pacifici, Massimo Milione, (unknown), Claudia Maggi, Gabriella Montemurro, Ilaria Bossi, Luigi Mariani, Filippo de Braud	9
13	Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies 2014 ·PLoS ONE ·Roberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, Claudia Maggi, Antonella Palazzo, (unknown), Filippo de Braud, Maria Di Bartolomeo	51
14	Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 2013 ·Annals of Oncology ·Filippo Pietrantonio, Federica Perrone, Filippo de Braud, (unknown), Claudia Maggi, (unknown), Arpine Gevorgyan, Pamela Biondani, Monica Pacifici, Adele Busico, Manuela Gariboldi, (unknown), Elena Tamborini, Maria Di Bartolomeo	50
15	Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens 2013 ·Cancer Biology & Therapy ·Filippo Pietrantonio, Federica Perrone, Pamela Biondani, Claudia Maggi, Andrea Lampis, Cláudia Bertan, Filippo Venturini, Luca Tondulli, Daris Ferrari, Vincenzo Ricci, Federica Villa, Gloria Barone, Nadia Bianco, Antonio Ghidini, Ilaria Bossi, Giuseppe Fanetti, Maria Di Bartolomeo, Filippo de Braud	24
16	Breast MRI: are T2 IR sequences useful in the evaluation of breast lesions? 2010 ·Clinical Imaging ·Laura Ballesio, Sara Savelli, (unknown), L. M. Porfiri, (unknown), Claudia Maggi, (unknown), P. Bennati, (unknown), Annarita Vestri, Lucia Manganaro	2
17	Role of breast Magnetic Resonance Imaging (MRI) in patients with unilateral nipple discharge: preliminary study 2008 ·La radiologia medica ·Laura Ballesio, Claudia Maggi, Sara Savelli, Mauro Angeletti, Carlo de Felice, (unknown), Lucia Manganaro, L. M. Porfiri	41
18	Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions? 2008 ·European Journal of Radiology ·Laura Ballesio, Sara Savelli, (unknown), L. M. Porfiri, (unknown), Claudia Maggi, Elisabetta Di Castro, P. Bennati, (unknown), Anna Rita Vestri, Lucia Manganaro	30
19	Evaluation of normal brain development by prenatal MR imaging 2007 ·La radiologia medica ·Lucia Manganaro, Anna Perrone, Sara Savelli, Marco Di Maurizio, Claudia Maggi, Laura Ballesio, L. M. Porfiri, Carlo de Felice, Emanuela Marinoni, Mario Marini	32
20	Comparison of somatostatin and cimetidine in the treatment of acute bleeding esophageal varices 1986 ·Current Therapeutic Research ·Pier Alberto Testoni, E. Masci, Sandro Passaretti, (unknown), A. Tittobello, U Comin, Elena Ballarín, Claudia Maggi, R Arcidiacono	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact